Skip to main content
Signal8

T2 Biosystems, Inc. (TTOO)

Sector: Medical - Diagnostics & Research

Industry: Medical - Diagnostics & Research

T2 Biosystems, Inc. logo

T2 Biosystems, Inc.

OTC:TTOOHealthcare
$0.0004
CLOSED
Mkt Cap$11K
EV-
Float28.05M
O/S28.05M
VOL1K sh
$ Vol$2
RVOL0.07×
Inst Own0.0%
SI<0.1%
Net Cash/Sh-
Dilution
T2 Biosystems, Inc. logoOTC:TTOOClosed$0.0004
Historical Data
DateOpenHighLowCloseVolume
Nov 16, 20260.00400.00400.00040.00041,151
Nov 13, 20260.00040.01000.00040.010013,909
Nov 12, 20260.00040.00900.00040.0090749
Nov 11, 20260.00070.01000.00070.0090133,412
Nov 9, 20260.00070.01000.00070.0100631
Nov 6, 20260.00070.00070.00020.000243,011
Nov 5, 20260.00200.00200.00040.00045,001
Nov 4, 20260.00050.00050.00050.00051,178
Nov 2, 20260.00080.00080.00080.0008877
Oct 30, 20260.00070.00070.00070.000710,410
Oct 29, 20260.00070.00070.00070.00071,701
Oct 28, 20260.00060.00060.00060.00061,918
Oct 27, 20260.00050.00050.00050.000510,508
Oct 26, 20260.00060.00060.00060.000623,672
Oct 23, 20260.00060.00060.00060.0006142
Oct 22, 20260.00060.00060.00060.0006311
Oct 21, 20260.00080.00080.00080.00081,513
Oct 20, 20260.00080.00080.00080.000828,142
Oct 16, 20260.00070.00070.00070.0007117
Oct 15, 20260.00070.00070.00070.00073,582
Analyst Coverage
Analyst Coverage
ConsensusHold
Price Target
Not available
Ratings Distribution
BUY
3
HOLD
6
SELL
1
TOTAL10
Insider Trades
InsiderTypeShares
Sprague John M profile photoSprague John MGrant/Award180.0K
LIEBMAN SEYMOUR profile photoLIEBMAN SEYMOURGrant/Award25.0K
Giffin Brett A. profile photoGiffin Brett A.Grant/Award180.0K
Giffin Brett A. profile photoGiffin Brett A.Grant/Award180.0K
Adams Laura Lee profile photoAdams Laura LeeGrant/Award25.0K
CUMMING JOHN W profile photoCUMMING JOHN WGrant/Award35.0K
Shareholders
0.0%
Institutional
(1)
0.0%
Insiderⓘ
(1)
0.0%
5%+ Owners
(0)
100.0%
Unattributed (incl. retail)ⓘ
Institutional0.0%
Insider0.0%
Unattributed (incl. retail)100.0%
Top Shareholders
Sources: 13F, Form 4, 13D/13GO/S: 28.0M · checked 8 Oct 2026 · market-data provider
Insiders & Institutional Holders

Insiders

Top institutional holders

About

T2 Biosystems, Inc. is an in vitro diagnostics company that develops and commercializes innovative diagnostic solutions for global markets.

Its proprietary technology platform enables the rapid detection of pathogens, biomarkers, and other critical abnormalities directly from a wide array of unpurified patient specimens, including whole blood, plasma, serum, saliva, sputum, cerebrospinal fluid, and urine.

The company's commercial offerings include the T2Dx Instrument, a compact bench-top system designed to run various diagnostic assays.

Its current suite of diagnostic tests features T2Candida, a direct-from-blood test that rapidly identifies bloodstream infections leading to sepsis and candidemia; T2Bacteria, another direct-from-blood assay for detecting bacterial pathogens commonly associated with sepsis; T2Resistance, which targets and identifies genes conferring carbapenem resistance; and the T2SARS-CoV-2 panel, developed to detect the SARS-CoV-2 virus.

In addition to its existing products, T2 Biosystems is actively advancing several diagnostic candidates. These include T2Biothreat, aimed at identifying biothreat pathogens; a comprehensive sepsis panel designed to detect bloodstream infections caused by both bacterial and Candida species, along with antibiotic resistance markers; T2Cauris, which offers direct detection of the emerging superbug Candida auris in patient skin, blood, and hospital environmental samples; and T2Lyme, a direct-from-blood test panel specifically engineered for the T2Dx Instrument to identify the bacteria responsible for Lyme disease. T2 Biosystems has also established strategic partnerships, such as its collaboration with Canon U.S. Life Sciences, Inc., to jointly develop a diagnostic test panel for Lyme disease.

The company was founded in 2006 and is headquartered in Lexington, Massachusetts.

Key Metrics
Market Cap$11,218
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership0.00%

based on 28.05M shares outstanding

SectorHealthcare
IndustryMedical - Diagnostics & Research
ExchangeOTC
CountryUSUS
IPO DateAug 7, 2014
Shares Outstanding28.05M
Authorized Shares
Float28.05M
52-Week Range
$0.0001$0.0500
$0.0004(1st percentile)
Volume
Average Daily Volume15.46K
1.15K today vs 15.46K avg(-93%)

30d Avg

15.46K

60d Avg

11.03K

90d Avg

11.00K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...

T2 Biosystems, Inc. (OTC: TTOO) traded at $0.0004 on Nov 16, 2026. 52-week range: $0.0001 to $0.0500. The company is in the Healthcare sector (Medical - Diagnostics & Research).